Sensipar Cinacalcet Pbs Listing To Be Deleted

Sensipar Cinacalcet Pbs Listing To Be Deleted. Apr 01, 2015 · cinacalcet was relisted on the pbs on 1 february 2020. Pbs listing occurred on 1 july 2008.

Kidney therapy reappears on the PBS - BioPharmaDispatch
Kidney therapy reappears on the PBS - BioPharmaDispatch from e76bb9fd1f54a7a912eb-40f6ec802f763655ee14c32dfe77820e.ssl.cf4.rackcdn.com
Publication details of the evolve trial are presented in the table below. The submission stated that the evolve trial results were consistent with the clinical claims made in the previous november 2007 submission. What do you need to know about sensipar?

Cinacalcet may be used to treat the biochemical manifestations of secondary hyperparathyroidism in patients with end stage renal disease, receiving dialysis.

See full list on pbs.gov.au See recommendations and reasons for the pbac's view. Sensipar is registered by the tga for the following indication: Pbs listing occurred on 1 july 2008.


Post a Comment for "Sensipar Cinacalcet Pbs Listing To Be Deleted"